News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
751,414 Results
Type
Article (51674)
Company Profile (328)
Press Release (699412)
Section
Business (219022)
Career Advice (2611)
Deals (38013)
Drug Delivery (115)
Drug Development (85361)
Employer Resources (179)
FDA (17061)
Job Trends (16046)
News (370150)
Policy (35636)
Tag
2024 BioCapital Digital (13)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (10)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (7)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (8)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (7)
2024 Pharm Country Standard (6)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2775)
Academic (1)
Accelerated approval (2)
Adcomms (22)
Allergies (82)
Alliances (54062)
ALS (86)
Alzheimer's disease (1377)
Antibody-drug conjugate (ADC) (119)
Approvals (17032)
Artificial intelligence (262)
Autoimmune disease (13)
Automation (14)
Bankruptcy (378)
Best Places to Work (12126)
BIOSECURE Act (20)
Biosimilars (103)
Biotechnology (211)
Bladder cancer (53)
Brain cancer (27)
Breast cancer (249)
Cancer (1913)
Cardiovascular disease (152)
Career advice (2191)
Career pathing (31)
CAR-T (143)
Cell therapy (416)
Cervical cancer (15)
Clinical research (68729)
Collaboration (769)
Compensation (424)
Complete response letters (27)
COVID-19 (2760)
CRISPR (41)
C-suite (199)
Cystic fibrosis (103)
Data (1804)
Decentralized trials (2)
Denatured (30)
Depression (43)
Diabetes (240)
Diagnostics (6564)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (130)
Drug pricing (116)
Drug shortages (30)
Duchenne muscular dystrophy (74)
Earnings (90626)
Editorial (38)
Employer branding (23)
Employer resources (156)
Events (119419)
Executive appointments (634)
FDA (18102)
Featured Employer (51)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (674)
Gene editing (102)
Generative AI (28)
Gene therapy (295)
GLP-1 (748)
Government (4758)
Grass and pollen (4)
Guidances (47)
Healthcare (19790)
Huntington's disease (23)
IgA nephropathy (23)
Immunology and inflammation (102)
Indications (25)
Infectious disease (2885)
Inflammatory bowel disease (140)
Inflation Reduction Act (10)
Influenza (45)
Intellectual property (75)
Interviews (451)
IPO (16987)
IRA (50)
Job creations (4377)
Job search strategy (1846)
Kidney cancer (9)
Labor market (29)
Layoffs (491)
Leadership (17)
Legal (8960)
Liver cancer (72)
Lung cancer (274)
Lymphoma (127)
Machine learning (2)
Management (62)
Manufacturing (280)
MASH (59)
Medical device (13845)
Medtech (13850)
Mergers & acquisitions (21457)
Metabolic disorders (643)
Multiple sclerosis (65)
NASH (19)
Neurodegenerative disease (82)
Neuropsychiatric disorders (29)
Neuroscience (1862)
NextGen: Class of 2025 (7039)
Non-profit (4798)
Northern California (2290)
Now hiring (36)
Obesity (356)
Opinion (249)
Ovarian cancer (63)
Pain (81)
Pancreatic cancer (73)
Parkinson's disease (128)
Partnered (18)
Patents (194)
Patient recruitment (86)
Peanut (49)
People (60983)
Pharmaceutical (95)
Pharmacy benefit managers (21)
Phase I (21262)
Phase II (30091)
Phase III (22710)
Pipeline (864)
Podcasts (94)
Policy (123)
Postmarket research (2901)
Preclinical (9156)
Press Release (69)
Prostate cancer (91)
Psychedelics (33)
Radiopharmaceuticals (257)
Rare diseases (372)
Real estate (6570)
Recruiting (69)
Regulatory (23867)
Reports (45)
Research institute (2486)
Resumes & cover letters (423)
Rett syndrome (3)
RNA editing (2)
RSV (40)
Schizophrenia (70)
Series A (122)
Series B (72)
Service/supplier (13)
Sickle cell disease (55)
Southern California (1986)
Special edition (17)
Sponsored (30)
Startups (3885)
State (2)
Stomach cancer (14)
Supply chain (61)
The Weekly (63)
United States (20548)
Vaccines (698)
Venture capitalists (36)
Webinars (12)
Weight loss (257)
Women's health (32)
Worklife (15)
Date
Today (83)
Last 7 days (611)
Last 30 days (3218)
Last 365 days (35669)
2025 (6868)
2024 (36755)
2023 (41381)
2022 (52637)
2021 (57362)
2020 (56111)
2019 (49172)
2018 (37255)
2017 (34553)
2016 (34578)
2015 (40531)
2014 (34794)
2013 (30322)
2012 (32189)
2011 (32632)
2010 (31076)
Location
Africa (932)
Alabama (51)
Alaska (7)
Arizona (226)
Arkansas (13)
Asia (43312)
Australia (7089)
California (5276)
Canada (1816)
China (445)
Colorado (243)
Connecticut (264)
Delaware (122)
Europe (94677)
Florida (779)
Georgia (184)
Idaho (60)
Illinois (506)
India (24)
Indiana (296)
Iowa (7)
Japan (134)
Kansas (100)
Kentucky (24)
Louisiana (8)
Maine (62)
Maryland (829)
Massachusetts (4073)
Michigan (211)
Minnesota (357)
Mississippi (2)
Missouri (76)
Montana (27)
Nebraska (26)
Nevada (54)
New Hampshire (67)
New Jersey (1522)
New Mexico (29)
New York (1512)
North Carolina (945)
North Dakota (7)
Northern California (2290)
Ohio (188)
Oklahoma (14)
Oregon (38)
Pennsylvania (1194)
Puerto Rico (6)
Rhode Island (25)
South America (1323)
South Carolina (16)
South Dakota (1)
Southern California (1986)
Tennessee (89)
Texas (775)
Utah (163)
Virginia (133)
Washington D.C. (59)
Washington State (506)
West Virginia (3)
Wisconsin (48)
751,414 Results for "aragon pharmaceuticals inc acquired by johnson and johnson".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Proteologix, Inc. to be Acquired by Johnson & Johnson
Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated diseases, today announced that it has entered into a definitive agreement to be acquired by Johnson & Johnson
May 16, 2024
·
2 min read
Press Releases
Johnson & Johnson MedTech Showcases New Era of Digital Orthopaedics at AAOS 2025
March 11, 2025
·
14 min read
Deals
Johnson & Johnson to Acquire Shockwave Medical
Johnson & Johnson and Shockwave Medical, Inc. announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire all outstanding shares of Shockwave for $335.00 per share in cash, corresponding to an enterprise value of approximately $13.1 billion including cash acquired.
April 5, 2024
·
15 min read
Deals
Johnson & Johnson to Acquire Proteologix, Inc. to Lead in Atopic Dermatitis Treatment
Acquisition advances Johnson & Johnson’s leading Dermatology portfolio with opportunity to address significant unmet need in atopic dermatitis (AD).
May 16, 2024
·
8 min read
Press Releases
Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc.
January 13, 2025
·
20 min read
Press Releases
Genmab Announces Johnson & Johnson Decision Regarding HexaBody®-CD38
March 10, 2025
·
6 min read
Press Releases
TuHURA Biosciences, Inc Appoints Craig L. Tendler M.D., Former Vice President, Oncology Clinical Development, Diagnostics, and Global Medical Affairs, Johnson & Johnson Innovative Medicine Research & Development, to its Board of Directors
March 12, 2025
·
8 min read
Press Releases
Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
March 5, 2025
·
1 min read
Press Releases
Johnson & Johnson’s DARZALEX® (daratumumab) subcutaneous-based regimen receives positive CHMP opinion for patients with newly diagnosed multiple myeloma, regardless of transplant eligibility
March 3, 2025
·
13 min read
Press Releases
Johnson & Johnson Announces Darren Snellgrove as Vice President, Investor Relations
March 5, 2025
·
2 min read
1 of 75,142
Next
